Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 18, 2024 - Issue
Submit an article Journal homepage
39
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

A-Ching Chao1 Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;2 College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanView further author information
,
Tsong-Hai Lee3 Stroke Center and Department of Neurology, Linkou Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Taoyuan, TaiwanORCID Iconhttps://orcid.org/0000-0002-3935-5963View further author information
ORCID Icon,
Luther C Pettigrew4 Department of Neurology, University of Kentucky Chandler Medical Center, Lexington, KY, USAORCID Iconhttps://orcid.org/0000-0001-7878-5803View further author information
ORCID Icon,
Yousef Hannawi5 Division of Cerebrovascular Diseases and Neurocritical Care, Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USAORCID Iconhttps://orcid.org/0000-0001-8614-3974View further author information
ORCID Icon,
Hung-Yu Huang6 Department of Neurology, China Medical University Hospital, Taichung, TaiwanORCID Iconhttps://orcid.org/0000-0001-6068-6954View further author information
ORCID Icon,
Nai-Fang Chi7 School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;8 Division of Cerebrovascular Diseases, Neurological Institute, Taipei Veterans General Hospital, Taipei, TaiwanORCID Iconhttps://orcid.org/0000-0002-2204-4923View further author information
ORCID Icon,
Lung Chan9 Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan;10 Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, TaiwanORCID Iconhttps://orcid.org/0000-0001-5795-4460View further author information
ORCID Icon,
Po-Lin Chen11 Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung, TaiwanView further author information
&
Thomas Devlin12 CHI Memorial Neuroscience Institute, Chattanooga, TN, USA;13 Department of Neurology, Morehouse School of Medicine, Atlanta, GA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6566-6565View further author information
ORCID Icon show all
Pages 2033-2042 | Received 06 Mar 2024, Accepted 23 May 2024, Published online: 06 Jun 2024

References

  • Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–211. doi:10.1055/s-0038-1649503
  • Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca
  • Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology. 2010;17(3):197–218. doi:10.1016/j.pathophys.2009.12.001
  • Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J. Streamlining of prehospital stroke management: the golden hour. Lancet Neurol. 2013;12(6):585–596. doi:10.1016/S1474-4422(13)70100-5
  • Belew M, Gerdin B, Porath J, Saldeen T. Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin. Thromb Res. 1978;13(6):983–994. doi:10.1016/0049-3848(78)90227-X
  • Mehta JL, Nichols WW, Saldeen TG. Effects of peptide 6A on coronary blood flow dynamics in canine coronary thrombosis. J Cardiovasc Pharmacol. 1989;13(6):803–811. doi:10.1097/00005344-198906000-00001
  • Zhao M, Wang C, Yang J, et al. Identification, synthesis and bioassay for the metabolites of P6A. Bioorg Med Chem. 2003;11(23):4913–4920. doi:10.1016/j.bmc.2003.09.021
  • Feng Q, Zhao M, Gan T, et al. DHDMIQK(KAP): a novel nano-delivery system of dihydroxyl-tetrahydro-isoquinoline-3-carboxylic acid and KPAK towards the thrombus. J Mater Chem B. 2016;4(36):5991–6003. doi:10.1039/C6TB00874G
  • Myers DD, Hawley AE, Farris DM, et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg. 2003;38(5):1075–1089. doi:10.1016/S0741-5214(03)01033-4
  • Jiang Y, Ji Y, Zhou IY, et al. Effects of the new thrombolytic compound LT3001 on acute brain tissue damage after focal embolic stroke in Rats. Transl Stroke Res. 2022;15(1):30–40.
  • Preclinical efficacy of Repetitive Dose of LT3001 in rat embolic stroke model once a day for 6 days. [ Unpublished data]. Lumosa Therapeutics; 2018.
  • Preclinical efficacy of Repetitive Dose of LT3001 in rat embolic stroke model three times a day for 6 days. [ Unpublished data]. Lumosa Therapeutics; 2019.
  • Safety, tolerability, and pharmacokinetics of single dose of LT3001 drug product in healthy subjects. [ Unpublished data]. Lumosa Therapeutics; 2019.
  • Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(2):581–641. doi:10.1161/STR.0000000000000086
  • National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–1587. doi:10.1056/NEJM199512143332401
  • Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019;380(19):1795–1803. doi:10.1056/NEJMoa1813046
  • Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018;379(7):611–622. doi:10.1056/NEJMoa1804355
  • Brunser AM, Ouyang M, Arima H, et al. No benefit of flat head positioning in early moderate–severe acute ischaemic stroke: a HeadPoST study subgroup analysis. Stroke Vasc Neurol. 2020;5(4):406–409. doi:10.1136/svn-2020-000387
  • Asuzu D, Nystrom K, Amin H, et al. Modest association between the discharge modified Rankin scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis. J Stroke Cerebrovasc Dis. 2015;24(3):548–553. doi:10.1016/j.jstrokecerebrovasdis.2014.09.034
  • Brown C, Terrell K, Goodwin R, Nathaniel T. Stroke severity in ischemic stroke patients with a history of diastolic blood pressure treated in a telestroke network. J Cardiovasc Dev Dis. 2022;9(10):345. doi:10.3390/jcdd9100345
  • Poupore N, Okon M, Mackey T, Nathaniel TI. Pre-stroke factors (morbitities, diet, medication, demograhics) that affect the severity of a stroke. Thromb Update. 2021;5:100073. doi:10.1016/j.tru.2021.100073

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.